Evidence for the extent and oncological benefit of lymphadenectomy for esophageal cancer

被引:0
|
作者
Krauss, Dolores T.
Schmidt, Thomas
Bruns, Christiane J.
Fuchs, Hans F. [1 ,2 ]
机构
[1] Univ Cologne, Med Fak, Klin & Poliklin Allgemein Viszeral Thorax & Transp, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Uniklin Koln, Kerpener Str 62, D-50937 Cologne, Germany
来源
CHIRURGIE | 2025年
关键词
Esophagectomy; Early stage cancer; Lymph node metastases; Tumor staging; Surgical technique; LYMPH-NODE; ADENOCARCINOMA; SAFETY; RESECTION; EFFICACY; IMPACT;
D O I
10.1007/s00104-024-02215-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
The prognosis for esophageal cancer is determined in particular by the depth of infiltration (T stage) and lymph node metastasis (N status). In patients with locally advanced tumors, surgical resection is the current standard. The extent of the lymphadenectomy depends on the localization of the tumor, analogous to the choice of surgical technique. For adequate tumor staging and achievement of pN0 status, seven lymph nodes without tumor metastases are necessary by definition but the current guidelines recommend 20 lymph nodes as a benchmark in an expert consensus. Despite the importance of the lymph node status for the prognosis of the patient and the already standardized use of targeted imaging of sentinel lymph nodes in other oncological disciplines, there is neither a validated method nor sufficient evidence for the benefit of lymph node mapping in esophageal cancer. The discussion about the prognostic advantage of lymphadenectomy is particularly interesting in T1 early stage cancer. Due to the technical advances of interventional endoscopy in recent years, organ preservation using endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) has not only become possible but also safe to carry out and thus established as the standard with better functional results; however, if one or more risk factors are present, endoscopic ablation is no longer defined as curative and should be supplemented by further treatment, usually non-organ-preserving resection. The step from organ-preserving interventional treatment with a low complication rate to a surgical procedure with significant mortality and morbidity as well as functional limitations seems immense and requires optimization, especially in view of the technical developments of surgery in recent years. This can either aim to identify the risk of lymph node metastases more precisely or to minimize the morbidity/mortality and functional limitations of additive treatment procedures. Approaches to this are currently the subject of research and have already been safely applied in individual pilot projects.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Evidence for the extent and oncological benefit of lymphadenectomy for pancreatic cancer
    Keck, Tobias
    CHIRURGIE, 2025,
  • [2] Evidence for the extent and oncological benefit of lymphadenectomy in gastric cancer
    Kelm, Matthias
    Flemming, Sven
    Germer, Christoph-Thomas
    Seyfried, Florian
    CHIRURGIE, 2024,
  • [3] Evidence for the extent and oncological benefit of lymphadenectomy for gastrointestinal tumors
    Germer, C. -t.
    CHIRURGIE, 2025, 96 (04): : 271 - 272
  • [4] Extent of lymphadenectomy of esophageal cancer surgery
    Isono, K
    Ochiai, T
    Koide, Y
    XV WORLD CONGRESS OF COLLEGIUM INTERNATIONALE CHIRURGIAE DIGESTIVAE (CICD), 1996, : 71 - 74
  • [5] Extent of Lymphadenectomy in Operable Esophageal Cancer
    Shetty, Preethi S.
    Sawant, Abhijeet
    Mankar, Hemant
    Pramesh, C. S.
    ANNALS OF THORACIC SURGERY, 2017, 104 (01): : 375 - 375
  • [6] Evidenz für Ausmaß und onkologischen Nutzen der Lymphadenektomie beim ÖsophaguskarzinomEvidence for the extent and oncological benefit of lymphadenectomy for esophageal cancer
    Dolores T. Krauss
    Thomas Schmidt
    Christiane J. Bruns
    Hans F. Fuchs
    Die Chirurgie, 2025, 96 (4) : 273 - 280
  • [7] Clinical Impact of Lymphadenectomy Extent in Resectable Esophageal Cancer
    Roderich E. Schwarz
    David D. Smith
    Journal of Gastrointestinal Surgery, 2007, 11 : 1384 - 1394
  • [8] Clinical impact of lymphadenectomy extent in resectable esophageal cancer
    Schwarz, Roderich E.
    Smith, David D.
    GASTROENTEROLOGY, 2007, 132 (04) : A835 - A835
  • [9] The extent of lymphadenectomy in esophageal resection for cancer should be standardized
    Hagens, Eliza R. C.
    Henegouwen, Mark I. van Berge
    Cuesta, Miguel A.
    Gisbertz, Suzanne S.
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S713 - S723
  • [10] Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery
    Lagergren, Jesper
    Mattsson, Fredrik
    Zylstra, Janine
    Chang, Fuju
    Gossage, James
    Mason, Robert
    Lagergren, Pernilla
    Davies, Andrew
    JAMA SURGERY, 2016, 151 (01) : 32 - 39